Trials / Unknown
UnknownNCT03827941
Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
In this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.
Detailed description
In this study, investigators will examine the treatment effect of transcutaneous electrical nerve stimulation at auricular area with vagus nerve distribution on high-functioning individuals with autism. Specifically, investigators will choose two ear acupoints: heart and shenmen. Participants will be randomized to either 1 Hz or 20 Hz tVNS group (up to 5 times per week) for three weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 1 Hz Auricular transcutaneous electrical nerve stimulation | High-functioning individuals with autism randomized to this group will receive 1 Hz tVNS stimulation for 30 minutes/day up to 5 times/week for 3 weeks. |
| OTHER | 20 Hz Auricular transcutaneous electrical nerve stimulation | High-functioning individuals with autism randomized to this group will receive 1 Hz tVNS stimulation for 30 minutes/day up to 5 times/week for 3 weeks. |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2024-01-28
- Completion
- 2024-01-28
- First posted
- 2019-02-04
- Last updated
- 2022-09-09
Source: ClinicalTrials.gov record NCT03827941. Inclusion in this directory is not an endorsement.